Autonomix Medical, Inc. filed a Current Report on Form 8-K with the Securities and Exchange Commission on November 20, 2026. The filing indicates that the company posted an updated corporate presentation on its official website on that date. The document, referenced as Exhibit 99.1, is dated November 2026 and provides an updated overview of the company's business and financial status.
The filing notes that the information contained in the updated presentation and Item 7.01 of the report is being furnished and shall not be considered "filed" under the Securities Exchange Act of 1934. Consequently, the content is not intended to be incorporated by reference into any future filings under the Exchange Act or the Securities Act of 1933, unless specifically identified as such.
The report also lists the company's principal executive address as 21 Waterway Avenue, Suite 300, The Woodlands, TX 77380. The registrant’s telephone number is listed as (713) 588-6150. The company’s common stock trades on The Nasdaq Stock Market LLC under the ticker symbol AMIX.